Cardiovascular
In this section you will find Diagnostics Diseases Cardiovascular market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
3 Item(s)
per page
-
Diabetes, Metabolic Syndrome and Cardiovascular Disease
$3,400.00Published by TriMark Publications LLC on Apr 1st, 2009This report charts the changing landscape of the global diabetic population and explores the added health concerns resulting from the metabolic syndrome phenomenon and one of its major risk factors: cardiovascular disease (CVD). Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Stakeholder Insight: Hypertension - Multiple Layers of Therapy Cover all Eventualities
$15,200.00Published by Datamonitor on Dec 19th, 2005Hypertension is a deadly disease and an important global public health challenge. Datamonitor estimates that there are currently 192m people with hypertension in the seven major markets, and this number is set to rise to 212m by 2015. Yet, a significant fraction of this sizeable patient pool remains undiagnosed or aborts treatment, considerably limiting the size of the market. Learn More
3 Item(s)
per page
Cardiovascular
In this section you will find Diagnostics Diseases Cardiovascular market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
3 Item(s)
per page
-
Diabetes, Metabolic Syndrome and Cardiovascular Disease
$3,400.00Published by TriMark Publications LLC on Apr 1st, 2009This report charts the changing landscape of the global diabetic population and explores the added health concerns resulting from the metabolic syndrome phenomenon and one of its major risk factors: cardiovascular disease (CVD). Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Stakeholder Insight: Hypertension - Multiple Layers of Therapy Cover all Eventualities
$15,200.00Published by Datamonitor on Dec 19th, 2005Hypertension is a deadly disease and an important global public health challenge. Datamonitor estimates that there are currently 192m people with hypertension in the seven major markets, and this number is set to rise to 212m by 2015. Yet, a significant fraction of this sizeable patient pool remains undiagnosed or aborts treatment, considerably limiting the size of the market. Learn More
3 Item(s)
per page